Intellipharmaceutics Announces Pricing of $5.2 Million Public Offering of Common Shares and Warrants
27 mai 2016 09h29 HE
|
Intellipharmaceutics International Inc.
TORONTO, May 27, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Announces Proposed Public Offering of Units of Common Shares and Warrants
26 mai 2016 17h24 HE
|
Intellipharmaceutics International Inc.
TORONTO, May 26, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of...
Intellipharmaceutics Reports Director Election Results
19 avr. 2016 17h30 HE
|
Intellipharmaceutics International Inc.
TORONTO, April 19, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Announces First Quarter 2016 Results
15 avr. 2016 06h30 HE
|
Intellipharmaceutics International Inc.
TORONTO, April 15, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in...
Intellipharmaceutics to Present at the 28th Annual ROTH Conference
08 mars 2016 17h30 HE
|
Intellipharmaceutics International Inc.
TORONTO, March 08, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Announces 2015 Year End Results
26 févr. 2016 21h45 HE
|
Intellipharmaceutics International Inc.
TORONTO, Feb. 26, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the...
Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Keppra XR®
24 févr. 2016 22h03 HE
|
Intellipharmaceutics International Inc.
TORONTO, Feb. 24, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...
Intellipharmaceutics to Present at the Noble Financial Capital Markets’ 12th Annual Investor Conference
19 janv. 2016 10h00 HE
|
Intellipharmaceutics International Inc.
TORONTO, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
Intellipharmaceutics Announces Successful Bioequivalence Results for Abuse Deterrent Rexista™ Oxycodone XR
14 janv. 2016 07h30 HE
|
Intellipharmaceutics International Inc.
TORONTO, Jan. 14, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the...
Intellipharmaceutics to Present at the Biotech Showcase™
21 déc. 2015 15h15 HE
|
Intellipharmaceutics International Inc.
TORONTO, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I)("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...